Objectives: Our purpose was to demonstrate that strategically chosen implantable
cardioverter-defibrillator (ICD) ventricular tachycardia (VT) or ventricular fibrillation (VF) …

Background No precise tools exist to predict appropriate shocks in patients with a primary
prevention ICD. We sought to identify characteristics predictive of appropriate shocks in …

Background: Careful device programming is necessary to reduce inappropriate
antitachycardia pacing (ATP) and shock therapy in recipients of implantable cardioverter …

Aims To evaluate the incidences of and risk factors predisposing to appropriate and
inappropriate shocks and mortality in a 'real-world'population of patients with ischaemic …

Several trials demonstrated that a long detection interval and a high-rate cutoff reduced
implantable cardioverter-defibrillator (ICD) therapy in primary prevention patients. However …

Background—Three trials demonstrated recently that a long detection window reduces
implantable cardioverter-defibrillator (ICD) therapy in primary prevention patients. Avoid …

While the efficacy of the intracardiac defibrillators (ICDs) for primary prevention is not
disputed, the relevant studies were carried out a long time ago. Most pertinent trials …

Aims In subcutaneous implantable cardioverter defibrillator (S-ICD) recipients, the
UNTOUCHED study demonstrated a very low inappropriate shock rate on programming a …

Background The UNTOUCHED study will assess the safety and efficacy of the
subcutaneous implantable cardioverter defibrillator (S‐ICD) in the most common cohort of …

Objectives: The purpose of this randomized study was to determine whether a strategically
chosen standardized set of programmable settings is at least as effective as physician …